{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T21:40:55Z","timestamp":1777066855774,"version":"3.51.4"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"47","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The ideal ablation strategy and end point for persistent atrial fibrillation (AF) have not been well founded. Defining periprocedural AF termination as the end point of catheter ablation is still controversial. This meta-analysis aimed to analyze the differences between periprocedural AF termination and non-termination in the long-term AF recurrence rate and postoperative complications.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Randomized controlled trials (RCTs) were identified by a systematic search of electronic databases including PubMed, EMBASE, and Cochrane library from January 2008 to August 2019. The primary outcome was freedom from AF or any atrial arrhythmia without antiarrhythmic drugs at the long-term (\u226512 months) follow-up. The secondary outcome was overall postoperative complication rates. The risk ratio (RR) with 95% confidence interval (CI) was pooled for these outcomes. A forest plot, fixed-effects model or random-effect model, <jats:italic toggle=\"yes\">Q<\/jats:italic> test, I<jats:sup>2<\/jats:sup> statistic, and Egger funnel plot were used in the statistical analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Fourteen RCTs were included in this meta-analysis. Overall, no significant difference was found in freedom from AF at the long-term follow-up between patients in whom AF termination was achieved and not achieved (RR\u200a=\u200a0.93, 95% CI\u200a=\u200a0.78-1.09, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.36, I<jats:sup>2<\/jats:sup>\u200a=\u200a69%). Patients with AF non-termination had a lower complication occurrence rate than those with AF termination (RR\u200a=\u200a1.74, 95% CI\u200a=\u200a1.11-2.73, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.02, I<jats:sup>2<\/jats:sup>\u200a=\u200a0%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Our meta-analysis suggests that AF termination is not a reliable procedural end point during ablation of persistent AF.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000018045","type":"journal-article","created":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T06:58:05Z","timestamp":1574665085000},"page":"e18045","source":"Crossref","is-referenced-by-count":8,"title":["Is ablation to atrial fibrillation termination of persistent atrial fibrillation the end point?"],"prefix":"10.1097","volume":"98","author":[{"given":"Fanghui","family":"Li","sequence":"first","affiliation":[{"name":"Department of Cardiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Tu","sequence":"additional","affiliation":[{"name":"Department of Urology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongze","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Laboratory of Emergency Medicine, Department of Cardiology, West China Hospital"},{"name":"Disaster Medical Center, Sichuan University, Chengdu, Sichuan, PR China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Cardiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yisong","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Cardiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Laboratory of Emergency Medicine, Department of Cardiology, West China Hospital"},{"name":"Disaster Medical Center, Sichuan University, Chengdu, Sichuan, PR China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Cardiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongde","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Cardiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Cardiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Cardiology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2019,11]]},"reference":[{"key":"R1-20230915","first-page":"5","article-title":"An integrated management approach to atrial fibrillation","volume":"25","author":"Carter","year":"2016","journal-title":"J Am Heart Assoc Jan"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/CIRCRESAHA.114.303211","article-title":"The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms","volume":"114","author":"Andrade","year":"2014","journal-title":"Circ Res Apr 25"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jacc.2014.06.1172","article-title":"Atrial fibrillation ablation: translating basic mechanistic insights to the patient","volume":"64","author":"Nishida","year":"2014","journal-title":"J Am Coll Cardiol Aug 26"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/europace\/eur398","article-title":"Extracellular matrix alterations in the atria: insights into the mechanisms and perpetuation of atrial fibrillation","volume":"14","author":"Goudis","year":"2012","journal-title":"Europace"},{"key":"R5-20230915","first-page":"e199","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"130","author":"JCWLA","year":"2014","journal-title":"Circulation"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"1e467","DOI":"10.1016\/j.yjmcc.2009.09.001","article-title":"Extracellular matrix remodeling in atrial fibrosis: mechanisms and implications in atrial fibrillation","volume":"48","author":"Pellman","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"R7-20230915","first-page":"1","article-title":"Tryptase promotes the profibrotic phenotype transfer of atrial fibroblasts by PAR2 and PPAR\u03b3 pathway","volume":"12","author":"Tan","year":"2018","journal-title":"Arch Med Res"},{"key":"R8-20230915","first-page":"1210","article-title":"Ectopic activity induced by elevated atrial pressure in rabbit pulmonary vein in vitro","volume":"118","author":"LJHCB","year":"2005","journal-title":"Chin Med J (Engl)"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1161\/CIRCEP.115.001722","article-title":"Is ablation to termination the best strategy for ablation of persistent atrial fibrillation? Ablation to termination is not the best strategy during ablation","volume":"8","author":"Latchamsetty","year":"2015","journal-title":"Circ Arrhythm Electrophysiol Aug"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1161\/CIRCEP.114.001943","article-title":"Five-year outcome of catheter ablation of persistent atrial fibrillation using termination of atrial fibrillation as a procedural endpoint","volume":"8","author":"Scherr","year":"2015","journal-title":"Circ Arrhythm Electrophysiol Feb"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/jce.12407","article-title":"A prospective and randomized comparison of limited versus extensive atrial substrate modification after circumferential pulmonary vein isolation in nonparoxysmal atrial fibrillation","volume":"25","author":"Lin","year":"2014","journal-title":"J Cardiovasc Electrophysiol Aug"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ccep.2012.06.005","article-title":"Ablation for atrial fibrillation: termination of atrial fibrillation is not the end point","volume":"4","author":"Santangeli","year":"2012","journal-title":"Card Electrophysiol Clin Sep"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"3","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med Oct 18"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"Der Simonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2307\/3001666","article-title":"The combination of estimates from different experiments","volume":"10","author":"WG","year":"1954","journal-title":"Biometrics"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/jce.13206","article-title":"Ablation of complex fractionated electrograms with or without ADditional LINEar Lesions for Persistent Atrial Fibrillation (The ADLINE Trial)","volume":"28","author":"Ammar-Busch","year":"2017","journal-title":"J Cardiovasc Electrophysiol Jun"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.hrthm.2008.09.016","article-title":"Ablation for longstanding permanent atrial fibrillation: results from a randomized study comparing three different strategies","volume":"5","author":"Elayi","year":"2008","journal-title":"Heart Rhythm Dec"},{"key":"R20-20230915","first-page":"10","article-title":"Stand-alone pulmonary vein isolation versus pulmonary vein isolation with additional substrate modification as index ablation procedures in patients with persistent and long-standing persistent atrial fibrillation: the randomized alster-lost-AF Trial (Ablation at St. Georg Hospital for Long-Standing Persistent Atrial Fibrillation)","author":"Fink","year":"2017","journal-title":"Circ Arrhythm Electrophysiol Jul"},{"key":"R21-20230915","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijcard.2014.12.035","article-title":"Does isolation of the left atrial posterior wall improve clinical outcomes after radiofrequency catheter ablation for persistent atrial fibrillation? A prospective randomized clinical trial","volume":"181","author":"Kim","year":"2015","journal-title":"Int J Cardiol Feb 15"},{"key":"R22-20230915","first-page":"6","article-title":"Does additional electrogram guided ablation after linear ablation reduce recurrence after catheter ablation for longstanding persistent atrial fibrillation?. A prospective randomized study","volume":"7","author":"Kim","year":"2017","journal-title":"J Am Heart Assoc Feb"},{"key":"R23-20230915","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.hrthm.2016.12.033","article-title":"Impact of acute atrial fibrillation termination and prolongation of atrial fibrillation cycle length on the outcome of ablation of persistent atrial fibrillation: A substudy of the STAR AF II trial","volume":"14","author":"Kochhauser","year":"2017","journal-title":"Heart Rhythm Apr"},{"key":"R24-20230915","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/CIRCEP.107.748780","article-title":"Randomized evaluation of right atrial ablation after left atrial ablation of complex fractionated atrial electrograms for long-lasting persistent atrial fibrillation","volume":"1","author":"Oral","year":"2008","journal-title":"Circ Arrhythm Electrophysiol Apr"},{"issue":"(53)","key":"R25-20230915","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jacc.2008.10.054","article-title":"A randomized assessment of the incremental role of ablation of complex fractionated atrial electrograms after antral pulmonary vein isolation for long-lasting persistent atrial fibrillation","volume":"3","author":"Oral","year":"2009","journal-title":"J Am Coll Cardiol Mar"},{"key":"R26-20230915","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1161\/CIRCEP.113.001019","article-title":"Prognostic role of subsequent atrial tachycardias occurring during ablation of persistent atrial fibrillation: a prospective randomized trial","volume":"6","author":"Rostock","year":"2013","journal-title":"Circ Arrhythm Electrophysiol Dec"},{"key":"R27-20230915","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.amjcard.2017.03.027","article-title":"Comparison of direct current synchronized cardioversion to ibutilide-guided catheter ablation for long-term sinus rhythm maintenance after isolated pulmonary vein isolation of persistent atrial fibrillation","volume":"119","author":"Wang","year":"2017","journal-title":"Am J Cardiol Jun 15"},{"key":"R28-20230915","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/pace.13221","article-title":"Optimal endpoint for catheter ablation of longstanding persistent atrial fibrillation: a randomized clinical trial","volume":"41","author":"Wang","year":"2018","journal-title":"Pacing Clin Electrophysiol Feb"},{"key":"R29-20230915","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1161\/CIRCEP.114.002504","article-title":"No benefit of complex fractionated atrial electrogram ablation in addition to circumferential pulmonary vein ablation and linear ablation: benefit of complex ablation study","volume":"8","author":"Wong","year":"2015","journal-title":"Circ Arrhythm Electrophysiol Dec"},{"key":"R30-20230915","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.hrthm.2015.10.006","article-title":"Biatrial linear ablation in sustained nonpermanent AF: Results of the substrate modification with ablation and antiarrhythmic drugs in nonpermanent atrial fibrillation (SMAN-PAF) trial","volume":"13","author":"Wynn","year":"2016","journal-title":"Heart Rhythm Feb"},{"key":"R31-20230915","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ccep.2012.05.005","article-title":"Ablation of persistent atrial fibrillation: AF termination is the end point","volume":"4","author":"Shah","year":"2012","journal-title":"Card Electrophysiol Clin Sep"},{"key":"R32-20230915","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.2217\/pgs.15.117","article-title":"MicroRNA expression changes after atrial fibrillation catheter ablation","volume":"16","author":"Sardu","year":"2015","journal-title":"Pharmacogenomics Nov"},{"key":"R33-20230915","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijcard.2018.10.075","article-title":"Why is chronic obstructive pulmonary disease linked to atrial fibrillation? A systematic overview of the underlying mechanisms","volume":"276","author":"Mataresea","year":"2019","journal-title":"Int J Cardiol Feb"},{"key":"R34-20230915","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jdiacomp.2014.09.002","article-title":"Autonomic dysfunction is associated with brief episodes of atrial fibrillation in type 2 diabetes","volume":"29","author":"Rizzo","year":"2015","journal-title":"J Diabetes Complications Sept"},{"key":"R35-20230915","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jacc.2013.02.091","article-title":"Brief episodes of silent atrial fibrillation predict clinical vascular brain disease in type 2 diabetic patients","volume":"62","author":"Marfella","year":"2013","journal-title":"J Am Coll Cardiol Aug"},{"key":"R36-20230915","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/j.1540-8167.2009.01553.x","article-title":"Time to cardioversion of recurrent atrial arrhythmias after catheter ablation of atrial fibrillation and long-term clinical outcome","volume":"20","author":"Baman","year":"2009","journal-title":"J Cardiovasc Electrophysiol Dec"},{"issue":"(55)","key":"R37-20230915","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jacc.2009.11.040","article-title":"Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis","volume":"23","author":"de Vos","year":"2010","journal-title":"J Am Coll Cardiol Feb"},{"key":"R38-20230915","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1540-8167.2011.02137.x","article-title":"Effect of catheter ablation on progression of paroxysmal atrial fibrillation","volume":"23","author":"Jongnarangsin","year":"2012","journal-title":"J Cardiovasc Electrophysiol Jan"},{"key":"R39-20230915","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1161\/CIRCEP.113.000471","article-title":"Long-term follow-up after catheter ablation of paroxysmal atrial fibrillation: the incidence of recurrence and progression of atrial fibrillation","volume":"7","author":"Takigawa","year":"2014","journal-title":"Circ Arrhythm Electrophysiol Apr"},{"key":"R40-20230915","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.amjcard.2017.01.040","article-title":"Effects of \u03b1-Lipoic acid on multiple cytokines and biomarkers and recurrence of atrial fibrillation within one year of catheter ablation","volume":"119","author":"Sardu","year":"2017","journal-title":"Am J Cardiol May"},{"key":"R41-20230915","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/ijcp.12823","article-title":"Telemonitoring in heart failure patients treated by cardiac resynchronisation therapy with defibrillator (CRT-D): the TELECART Study","volume":"70","author":"Sardu","year":"2016","journal-title":"Int J Clin Pract July"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000018045","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T22:04:07Z","timestamp":1694815447000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000018045"}},"subtitle":["A systematic review and meta-analysis"],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":40,"journal-issue":{"issue":"47","published-online":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000018045","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11]]}}}